(4-Pack) BPC-157 CAPSULES – 500mcg / 30 Capsules
Notify me when back in stock
Related Products
Peer-Reviewed Literature
Related Studies
Peer-Reviewed Literature
Related Studies
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
HSS Journal
Analysis of 36 studies (1993–2024) found BPC-157 enhanced growth hormone receptor expression, angiogenic pathways, and reduced inflammatory cytokines with improved biomechanical outcomes in musculoskeletal injuries.
Gastric Pentadecapeptide Body Protection Compound BPC 157 and Its Role in Accelerating Musculoskeletal Soft Tissue Healing
Cell and Tissue Research
Comprehensive review concluding that all BPC-157 studies demonstrate consistently positive and prompt healing effects for various traumatic and systemic soft tissue injuries including tendons, ligaments, and skeletal muscle.
The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration
Journal of Applied Physiology
BPC 157 significantly accelerated tendon explant outgrowth, increased cell survival under oxidative stress, and markedly increased in vitro migration of tendon fibroblasts in a dose-dependent manner.
Gastric Pentadecapeptide BPC 157 Accelerates Healing of Transected Rat Achilles Tendon and In Vitro Stimulates Tendocytes Growth
Journal of Orthopaedic Research
BPC 157 improved tendon healing biomechanically (increased load-to-failure and elasticity), functionally, and microscopically — achieving superior fibroblast formation and collagen deposition.
BPC 157 Rescued NSAID-Cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
Current Pharmaceutical Design
BPC-157 counteracted NSAID-induced intestinal damage by stabilizing intestinal permeability, restoring cytoprotective prostaglandin systems, and recovering leaky-gut syndrome pathways.
Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL 14736, Pliva)
Current Pharmaceutical Design
Comprehensive review of BPC 157 clinical development for inflammatory bowel disease including ulcerative colitis trials, demonstrating mucosal healing and anti-inflammatory effects across multiple organ systems.